86.90.E - Other human health activities notelsewhere classified
70.22.Z - Business and other management consultancy activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.99.Z - Other business support service activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.22.Z - Specialist medical practice activities
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 2,2 | 1,2 | 0,8 | -33,3 |
Gross profit (loss) | 1,4 | -0,3 | -0,4 | -10,7 |
EBITDA | 1,8 | -0,1 | -0,1 | -29,8 |
Net profit (loss) | 1,3 | -0,3 | -0,4 | -10,7 |
Cash | 0,2 | 0,1 | 0,1 | -49,9 |
Net income from sale | 4,5 | 1,6 | 1 | -37,8 |
Liabilities and provisions for liabilities | 0,3 | 0,1 | 0,1 | -23 |
Short time liabilities | 0,3 | 0,1 | 0,1 | -23 |
Equity capital | 1,8 | 1,1 | 0,7 | -34,2 |
Working assets | 1,4 | 0,6 | 0,4 | -29,2 |
Operating profit (EBIT) | 1,4 | -0,3 | -0,4 | -10,6 |
Depreciation | 0,4 | 0,2 | 0,2 | 0 |
% | % | % | p.p. | |
Profitability of capital | 72,6 | -30,1 | -50,7 | -20,6 |
Equity capital to total assets | 85,4 | 91,9 | 90,7 | -1,2 |
Gross profit margin | 31,3 | -20,4 | -36,3 | -15,9 |
EBITDA Margin | 40,1 | -7,3 | -15,2 | -7,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 25 | 22 | 27 | 5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane